Palbociclib Intermediates

VIDGASTECH provides Palbociclib Intermediates with high purity and stability, supporting the synthesis of CDK4/6 inhibitors for breast cancer treatment

Additional Content with Keywords:
VIDGASTECH specializes in pharmaceutical-grade Palbociclib API intermediates, essential for the production of CDK4/6 inhibitors used in HR-positive, HER2-negative breast cancer treatment. With strict GMP compliance, high-purity synthesis, and quality assurance, our intermediates support efficient drug formulation and active pharmaceutical ingredient (API) manufacturing. As a trusted supplier of oncology drug intermediates, we cater to global pharmaceutical companies developing targeted anticancer therapies. Contact us for bulk API intermediates and custom synthesis solutions.5-bromo-2-chloro-N- cyclopentylpyrimidin-4- amine 733039-20-8 2-chloro-8-cyclopentyl-5- methylpyrido[2,3-d]pyrimidin- 7(8H)- one 1013916-37-4 6-bromo-2-chloro-8-cyclopentyl-5- methylpyrido[2,3- d]pyrimidin-7(8H)- one 1016636-76-2 tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1- carboxylate 571188-59-5 5 tert-butyl 4-(6-((6-bromo-8- cyclopentyl-5- methyl-7-oxo- 7,8- dihydropyrido[2,3- d]pyrimidin-2- yl)amino)pyridin-3- yl)piperazine-1- carboxylate 571188-82-4 5-Bromo-2,4-dichloropyrimidine 36082-50-5 5-bromo uracil 51-20-7